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Abstract: Syzygium polyanthum (S. polyanthum), a plant belonging to Myrtaceae, is widely
used in Indonesian and Malaysian cuisines. Diabetic patients in Indonesia also commonly
use it as a traditional medicine. Hence, this study was conducted to investigate the
antihyperglycemic effect of the methanol extract (ME) of S. polyanthum leaf and its possible
mechanisms of action. To test for hypoglycemic activity, ME was administered orally to
normal male Sprague Dawley rats after a 12-h fast. To further test for antihyperglycemic
activity, the same treatment was administered to glucose-loaded (intraperitoneal glucose
tolerance test, IPGTT) and streptozotocin (STZ)-induced diabetic rats, respectively.
Hypoglycemic test in normal rats did not show significant reduction in blood glucose
levels (BGLs) by the extract. Furthermore, IPGTT conducted on glucose-loaded normal
rats also did not show significant reduction of BGLs. However, repeated administration of
metformin and three doses of ME (250, 500 and 1000 mg/kg) for six days caused significant
reduction of fasting BGLs in STZ-induced diabetic rats. The possible mechanisms of
action of S. polyanthum antihyperglycemic activity were assessed by measurement of
intestinal glucose absorption and glucose uptake by isolated rat abdominal muscle. It was
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found that the extract not only inhibited glucose absorption from the intestine but also
significantly increased glucose uptake in muscle tissue. A preliminary phytochemical
qualitative analysis of ME indicated the presence of tannins, glycosides, flavonoids,
alkaloids and saponins. Additionally, Gas Chromatography-Mass Spectrometry (GC-MS)
analysis detected squalene. In conclusion, S. polyanthum methanol leaf extract exerts its
antihyperglycemic effect possibly by inhibiting glucose absorption from the intestine and
promoting glucose uptake by the muscles.
Keywords: antihyperglycemic; Syzygium polyanthum (Wight.); leaf; methanol extract
1. Introduction
Diabetes Mellitus (DM) is the number one killer among all chronic diseases in the world [2] and
Asians make up more than 60% of the world’s diabetic population [3]. The main symptom of DM is
hyperglycemia, which leads to many complications classifiedinto “microvascular” and “macrovascular”.
Microvascular complications, such as diabetic nephropathy and diabetic retinopathy, result from
damages to the small blood vessels, whereas the macrovascular complications are caused by damages to
arteries, leading to coronary artery and periphery artery diseases, and stroke.
Basically, hyperglycemia is the result of relative insulin deficiency, insulin resistance or both [4,5],
which renders the cells unable to store glucose. Therefore, the goal of pharmacotherapy is to normalize
the blood glucose levels [6]. Currently available conventional antihyperglycemic agents may be divided
into a few classes that act to slow glucose absorption from the gut, increasing insulin secretion by
β-cells, or increase insulin sensitivity at target tissues. Unfortunately, these oral antidiabetic agents have
been reported to precipitate many side effects such as hypoglycemia, weight gain, hepatic dysfunction,
metallic taste, abdominal discomfort, etc. Therefore, many diabetic patients are inclined to use
alternative therapies or traditional herbal medicines, one of which is Syzygium polyanthum (Wight).
Syzygium polyanthum (S. polyanthum), as in Figure 1, is widely used in Indonesian and Malaysian
cuisines and is also traditionally used in the treatment of diabetes in Indonesia [7,8]. This plant,
belonging to Myrtaceae family, is widely distributed throughout Burma (Myanmar), Indo-China,
Thailand, Malaysia, and Indonesia (Java, Sumatera, Kalimantan) [7], and has common names, such
as ubar serai, meselengan (Sumatera); samak, kelat samak, serah (Malaysia); manting (Jawa), and
Indonesian bay-leaf or Indonesia laurel [7,9]. Phytochemical screening showed that its leaves contained
essential oils, tannins, flavonoids, terpenoids and fatty acids [8–10]. Interestingly, Patel et al. [11]
reported that the antidiabetic activity of medicinal plants was attributed to the presence of polyphenols,
flavonoids, terpenoids and coumarins.
This study was conducted to investigate the hypoglycemic and antihyperglycemic effects of the
methanolic extract of S. polyanthum leaf, possible mechanisms of action, and phytochemical content.
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Figure 1. Syzygium polyanthum (Wight.). 
2. Materials and Methods 
2.1. Chemicals 
Over the course of this study, the following oral antidiabetic drugs were utilized: Glibenclamide 
(Clamide®) 10 mg, Acarbose (Glucobay®) 50 mg, and Metformin HCl British Pharmacopoeia (BP)  
500 mg, as positive controls for comparison purpose. Additionally, Insulin (NOVO RAPID Flex Pen®)  
100 IU/mL, and Glucose (R&M Chemicals, Essx, UK) were used. Streptozotocin was purchased from 
Sigma-Aldrih Chemical Company, St. Louis, MO,USA. Blood glucose levels were determined using 
Accu-Check Advantage Clinical Glucose meter (Roche diagnostics Co., IN, USA). 
2.2. Plant Material Collection and Preparation of Extracts 
Syzygium polyanthum (Wight.) leaves were collected from Titi Kuning, Medan, Indonesia and 
identified at the School of Biological Sciences,University of Sumatera Utara, Medan, Indonesia  
(No.13/MEDA/2012).The dried leaves were powdered using a milling machine. The powder, weighing 
about 1.5 kg, was sequentially extracted by maceration with three solvents to obtain methanol extract 
(ME). The initial extraction was conducted using petroleum ether (40–60 °C), followed by chloroform 
and, finally, methanol. The extracts obtained were filtered with Whatman No.1 filter paper and 
concentrated in vacuo by a rotary evaporator (Labortechnik, AG CH-9230, Postfach, Flawil, 
Switzerland) at reduced pressure.The concentrated extracts were dried in the oven (50 °C) to remove the 
remaining solvents and the dried extracts were kept in the freezer (−25 °C) until further use in the 
designated experiments. 
2.3. Animals 
Healthy male Sprague Dawley (SD) rats weighing between 200 and 250 g (n = 82) were obtained 
from the Animal Research and Service Center (ARASC), Universiti Sains Malaysia (USM), after 
approval by the Animal Ethics Committee of USM Penang, Malaysia (Approval Number: USM/ Animal 
Ethics Approval/2012/(76)(366)). The animals were acclimatized at room temperature (25–30 °C) for 
one week; and had access to food (standard laboratory chow, Gold Coin Holdings Sdn. Bhd., Kuala 
Lumpur, Malaysia) and water ad libitum under a 12-h light/12-h dark cycle [12]. 
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2.4. Hypoglycemic Test in Normal Rats
Normal male SD rats were divided into six groups (n = 6) and fasted overnight (8:00pm–8:00am).
The first group, the positive control group, was treated with glibenclamide (10 mg/kg). The second,
third, fourth and fifth groups were treated with ME (125 mg/kg, 250 mg/kg, 500 mg/kg, and 1 g/kg,
respectively). The sixth group served as the negative control and was treated with normal saline 0.9% (10
mL/kg). All treatments were administered orally using a 16-G oral needle. blood glucose levels (BGLs)
were measured before treatment and at the time intervals of 1, 2, 3, 5, and 7 h after each treatment.
2.5. Intraperitoneal Glucose Tolerance Test (IPGTT) in Normal Rats
Normal male SD rats were randomly divided into three groups (n = 6) and fasted overnight. The first
group was treated with normal saline (10 mL/kg). The second and third groups were given metformin
(500 mg/kg) and ME (1 g/kg), respectively. All treatments were administered orally. Sixty minutes after
drug/extract administration, all the rats were loaded with glucose by intraperitoneal injection (1 g/kg).
BGLs were measured from the tail vein before treatment (time 0) and 15, 30, 45, 60, 90, and 120 min
after the glucose load [12,13].
2.6. Induction of Experimental Diabetes
Streptozotocin solution (prepared in 0.9% NaCl solution, 55 mg/kg) was injected intraperitoneally to
overnight-fasted rats. The animals were then observed for 3 ˆ 24 h. After 3 days, the rats’ fasting blood
glucose levels were measured. The animals that showed blood glucose levels of 11 mmol/L and above
were included in the study.
2.7. Antihyperglycemic Test in STZ-Induced Diabetic Rats (SDRs)
Diabetic rats were equally divided into six groups (n = 6). The first group was administered with
metformin (500 mg/kg). The second, third, fourth and fifth groups were treated with ME (125 mg/kg,
250 mg/kg, 500 mg/kg, and 1 g/kg, respectively). The sixth group was treated with normal saline 0.9%
(10 mL/kg). All treatments were administered orally, twice daily, 12 h apart, for 6 days. BGLs were
measured before and 6 days after treatment.
2.8. Statistical Analysis
All data was expressed as mean ˘ standard error of the mean (SEM). Mean differences between the
groups were statistically analyzed by one-way analysis of variance (ANOVA) at the alpha value of 0.05
followed by Dunnett’stest as a post hoc test. Mean differences between pre-treatment and post-treatment
were analyzed by paired t-test. Differences were considered significant at p < 0.05.
2.9. Measurement of Glucose Absorption from Rat Everted Jejunal sacs
Glucose absorption from the intestine was determined according to Zurina et al. [13] with
modifications. Normal rats weighing 200–250 g (n = 4) were sacrificed and their abdominal walls
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dissected. The jejunum, identified as the segment located between 20–25 cm away from the pylorus,
was removed and placed in a Tyrode buffer solution (137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl2¨ 2H2O,
1.0 mM MgCl2, 12 mM NaHCO3, 0.2 mM NaH2PO2 and 5.5 mM glucose) and aerated with Carbogen
gas (95% O2 and 5% CO2). Isolated jejunum were everted using a rod, and cut into 5-cm length segments.
One end was tied tightly to form a sac, while the other end was tied loosely with a thread. Each sac was
filled with 1 mL of Tyrode’s solution by slipping a blunt needle attached to a syringe through the loose
end and tighten the knot as the needle was being withdrawn. Each sac was immersed in a solution
containing 1 mg/mL acarbose and/or ME; and one end of the thread was allowed to hang over the
opening of the tube. Samples were dissolved in distilled water. All of the tubes were then placed in
a water bath (37 ˝C) and incubated for 1 h. The sacs were removed from the test tubes by pulling on
the thread using a forceps after incubation. Three milliliters of the peridochrome-glucose reagent were
pipetted into each test tube. Next, 30 µL of each test solution were added into the respective tube. The
mixtures were incubated for 20 min in a water bath at 37 ˝C. Glucose concentration was determined by
using a Stat Fax machine 1937 (Awareness Technology Inc., FL, USA).
Glucose absorption was calculated using the following formula:
Glucose absorption (mgglucose{dL/gtissueq “ Glucose concentration before incubation´
Glucose concentration after absorption)/weight of the jejunum segment
(1)
2.10. Measurement of Glucose Uptake by Isolated Rat Abdominal Muscle
Glucose uptake by isolated rat abdominal muscle was measured according to Gray and Flatt [13,14]
with modifications. Normal SD rats (200–250 g) (n = 6) were sacrificed and skinned to expose the
abdominal muscle. The abdominal muscles were then excised without the rectus abdominus and were
cut into small squares (90–150 mg per muscle) and transferred into Kreb’s-Ringer bicarbonate buffer
solution (KRB; 18 mM NaCl, 5 mM KCl, 2.0 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, and
1.28 mM CaCl2) in the presence of 95% O2 and 5% CO2 at 37˝C. The muscle segments were then
placed in 1.5 mL eppendorf tubes containing KRB solution and were aerated for 10 min to allow them to
acclimatize. After acclimitization, the KRB solution was changed with a fresh KRB solution containing
11.1 mmol/L glucose. The muscles were then aerated for 5 min in the presence of test substances
with/without the presence of insulin. Insulin stock, obtained at the concentration of 100 IU/mL, was
utilized. A 50 IU solution was prepared by taking 500 µLinsulin at 100 IU/mLand adding 500 µL KRB
solution. In order to attain insulin at the final concentration of 1 IU/mL in 1 mL of KRB solution to run
the experiment using 1.5 mL eppendorf tubes, the calculation was made using the following formula:
(M1V1before dilution = M2V2after dilution); hence, V1 = ((1 IU/mL ˆ 1 mL)/(50 IU/mL)) = 0.02 mL = 20 µL
of insulin at 50 IU/mL. Likewise, 20 µL of the test substances, prepared at 50 mg/mL, were added
to the respective tubes. Thus, 960 µLof KRB solution made the volume up to 1 mL. Tubes without
insulin saw a similar calculation except that insulin was not added; hence, 20 µL of test substances at
50 mg/mL + 980 µL of KRB solution made up the final volume to 1 mL. Following the 5-min aeration,
the tubes were incubated for 30 min at 37 ˝C in a water bath. To determine glucose uptake, 3 mL
of Peridochrome-glucose reagent were pipetted into clean test tubes, into which 30 µL of each test
supernatant were added. Next, the mixtures were incubated for 20 min in a water bath at 37 ˝C; and
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glucose uptake by the muscles was measured by using a Stat Fax machine 1937 (Awareness Technology
Inc., FL, USA).
Calculation:
Glucose uptake pmmolglucose/dL/gtissueq “ ppamount of glucose before incubation




Phytochemical qualitative analysis was performed using the general method for phytochemical
screening of tannins, glycosides, flavonoids, alkaloids and saponins with modification [15,16].
2.11.1. Identification of Tannins
Half a gram of extract was stirred with 10 mL of distilled water and filtered. Four drops of a 1%
ferric chloride solution were added to 2 mL of the filtrate. Blue-black, green or blue-green precipitate
indicated the presence of tannins.
2.11.2. Identification of Glycosides
Half a gram of extract was dissolved in 1 mL of distilled water. Aqueous NaOH 2M was added to the
solution and the resulting yellow coloration indicated the presence of glycosides.
2.11.3. Identification of Flavonoids (Ferric Chloride Test)
Half a gram of extract was boiled with 3 mL of distilled water. The solution was then filtered; and
2 mL of the filtrate were mixed with 5 drops of a 10% ferric chloride solution. The color change to
green-blue or violet indicated the presence of the phenolic hydroxyl group.
2.11.4. Identification of Alkaloids (Dragendorff’s Test)
Approximately 0.2 g of extract were stirred with 5 mL of 1% hydrochloric acid (HCl) in a water bath.
The solution was filtered; and 1 mL of the filtrate was added to a test tube. Next, Dragendorff’s Reagent
was added to the filtrate. The presence of an orange color signaled the presence of alkaloids.
2.11.5. Identification of Saponins
Approximately 0.2 g of extract were dissolved in 5 mL of distilled water and the mixture was heated
until boiling. The solution was then cooled and filtered. Next, 3mL of distilled water wasadded to the
filtrate and the tube was shaken vigorously. Formation offrothindicatedthe presence of saponins.
2.12. Identification by Gas Chromatography-Mass Spectrometry (GC-MS)
ME was dissolved in methanol (1 mg/mL). So far, the literature has not shown any compound with
antidiabetic activity to have been reported in S.polyanthum. Therefore, our samples were analyzed using
GC-MS. Consequently, squalene was found in ME and was then purchased as a reference compound
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(Squalene (synonym:2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene((CH3)2C(=CHCH2
CH2C(CH3))2=CHCH2-)2; molecular weight 410.72, >98% liquid) from SIGMA. It was diluted in
methanol at a 1 mg/mL concentration.GC-MS analysis was conducted under the following conditions:
column used was HP-5MS; initial oven temperature was 70 ˝C (2 min) and was raised to 280 ˝C at
the rate of 20 ˝C per min; final time: 20 min; total run time: 32.50 min; flow: 1.2 mL/min;splitless.
One microliter of ME solution was injected into the GC apparatus. Mass spectrometry conditions: scan
parameter for low mass 35.0 and high mass 650.0; MS Quad: 150 ˝C; MS Source: 230 ˝C.The resulting
mass spectrum was analyzed using the database of the National Institute of Standards and Technology
(NIST 02). Squalene was considered a match with the match quality being >90%, which indicated good
similarity with the spectrum of squalene in the library. Confirmation of the result was conducted with
ion fractionation.
3. Results
3.1. Hypoglycemic Test and IPGTT in Normal Rats
Figure 2 shows the effects of glibenclamide and ME on BGLs. Oral treatment with ME (1 g/kg) did
not significantly alter BGLs of normal rats as compared to the control group during the 7-h observation
period. However, BGLs in glibenclamide (p < 0.01)-treated rats were significantly reduced from the 1st
until the 7th h after the oral treatment.
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Figure 2. Effects of the methanolic extract (ME) of S. polyanthum leaf, and glibenclamide 
on blood glucose levels of normal rats. Values are expressed as mean ± standard error of the 
mean (SEM) (n = 6); ** p < 0.01 compared with the control group. 
Figure 3 shows the IPGTT test in normal rats. The increase in BGLs upon glucose loading was not 
significantly altered by oral treatment with ME (1 g/kg), within 120 min after glucose loading. 
However, BGLs in metformin-treated group were significantly decreased at 90 and 120 min 
(p < 0.01, p < 0.05, respectively). 
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Figure 3 shows the IPGTT test in normal rats. The increase in BGLs upon glucose loading was
not significantly altered by oral treatment with ME (1 g/kg), within 120 min after glucose loading.
However, BGLs in metformin-treated group were significantly decreased at 90 and 120 min (p < 0.01,
p < 0.05, respectively).
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± standard error of the mean (SEM) (n = 6);* p < 0.05, ** p < 0.01 compared with the control 
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3.2. Antihyperglycemic Test in STZ-Induced Diabetic Rats (SDRs) 
Figure 4 depicts the antihyperglycemic effects of ME and metformin on BGLs after six days of oral 
administration twice daily. As shown below, oral administration of ME at a dose of 125 mg/kg did not 
manage to significantly decrease SDRs’ fasting BGLs. However, doses of 250 mg/kg, 500 mg/kg and 
1000 mg/kg of ME significantly (p < 0.05, p < 0.01, p < 0.001) and dose-dependently reduced their fasting 
BGLs. Likewise, metformin as a positive control caused a significant reduction (p < 0.01) in the BGLs. 
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3.2. Antihyperglycemic Test in STZ-Induced Diabetic Rats (SDRs)
Figure 4 depicts the antihyperglycemic effects of ME and metformin on BGLs after six days of oral
administration twice daily. As shown below, oral administration of E at a dose of 125 mg/kg did not
manage to significantly decrease SDRs’ fasting BGLs. However, doses of 250 mg/kg, 500 mg/kg and
1000 g/kg of ME significantly (p < 0.05, p < 0.01, p < 0.001) and dose-dependently reduced their
fasting BGLs. Likewise, metformin as a positive control caused a significant reduction (p < 0.01) in
the BGLs.
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3.3. Glucose Absorption from the Intestine
Figure 5 shows the in vitro effects of ME and acarbose on intestinal glucose absorption. As shown
below, in the absence of acarbose and ME, the amount of absorbed glucose was 198.2 mg/dL/g tissue
weight. Compared with the control, the presence of acarbose, however, caused a significant reduction
in glucose absorption (p < 0.01), decreasing the value to 128 mg/dL/g tissue weight. ME showed a
similar hopeful result as the amount of glucose absorbed was significantly reduced to 146.5 mg/dL/g
tissue weight, as compared with the control.
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3.4. Glucose Uptake by Isolated Rat Abdominal Muscle
Figures 6 and 7 show glucose uptake by isolated rat abdominal muscle in the presence and absence
of insulin. In normal isolated rat abdominal muscle, with the absence of insulin, a significant increase
(p < 0.05) in glucose uptake was observed in the metformin-treated group (377.7 ˘ 67.8 mmol/dL/g
tissue weight) when compared with the control group (158.1 ˘ 20.5 mmol/dL/g tissue weight).
Similarly, treatment with ME also elicited a significant increase in glucose uptake (p < 0.05)
(416.2 ˘ 59.9 mmol/dL/g tissue weight) when compared with the control in the absence of insulin. The
presence of insulin in the KRB solution significantly increased glucose uptake in both the metformin- and
ME-treated groups (471.9 ˘ 42.6 mmol/dL/g tissue weight (p < 0.001) and 428.6 ˘ 33.1 mmol/dL/g
tissue weight (p < 0.01), respectively) when compared with the control and insulin treatment alone.
3.5. Phytochemical Identification
Figure 8 depicts the phytochemical qualitative analysis aimed at detecting the presence of tannins,
glycosides, flavonoids and alkaloids in ME. Positive results were sho n for the tannins, glycosides,
flavonoids and alkaloids tests.
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3.6. GC-MS Analysis
GC-MS analysis of the methanolic extract of S. polyanthum leaf showed that it consisted of many
constituents (data not shown) that may contribute to its medicinal activity. The analysis was based on
the quality of matching with the library (>90%). Hence, only one compound was identified with high
certainty as squalene (Figure 9).
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4. Discussions
The present study was conducted in normal and diabetic rats to investigate the hypoglycemic and
antihyperglycemic effects of S.polyanthum (Wight) leaf methanolic extract. Preliminary studies were
conducted in normal rats. For the hypoglycemic test, an antidiabetic standard drug of the sulphonylureas
class (glibenclamide) was used as the positive control, whereas a biguanide (metformin) was chosen
for the IPGTT. The hypoglycemic test showed gl benclamide to reduce BGLs from the first hour up
until the seventh hour after oral administration. Glibenclamide acts by increasing insulin secretion
from the pancreatic beta cells by closing the adenosine triphosphate-sensitive potassium channels,
depolarizing beta cell plasma membranes, and increasingintracellular calcium concentrations—thus
stimulating insulin release. These actions are responsible for the effectiveness of glibenclamide in
decreasing both fasting blood glucose levels and postprandial hyperglycaemia [16]. Treatment with
a single dose of ME did not affect the BGLs of normal fasting rats. Hypoglycemia is a condition
characterized by low blood glucose levels, levels below 3.8 mmol/L. Glibenclamide at the present
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study showed the ability to reduce BGLs to be within the hypoglycemic range (5.9 ˘ 0.11 mmol/L
to 3.4 ˘ 0.05 mmol/L), which validated its activity as a hypoglycemic agent.
InIPGTT, only metformin inhibited the rise of BGLs significantly at the 90 and 120 min intervals
(p < 0.01, p < 0.05, respectively). Metformin, a biguanide, acts as an insulin sensitizer i.e., its blood
glucose lowering action does not depend on the presence of functioning pancreatic β-cells [17,18].
Patients with type 2 diabetes show considerably less fasting hyperglycemia as well as lower postprandial
hyperglycemia after biguanide intake. Therefore, biguanides are appropriately termed the “euglycemic”
agents [18]. Since ME showed insignificant effect in IPGTT in the normal rats, we conducted the test in
streptozotocin-induced diabetic rats.
Streptozotocin (STZ) is an antibiotic [19] that is naturally synthesized by Streptomycete
sachromogenes and is used in the laboratory to induce both type 1 and type 2 DM in animals [20]. STZ
causes pancreatic beta cell destruction, accompanied by hyperglycemia and a reduction of blood insulin
levels [20,21]. In STZ-induced diabetic rats, an antihyperglycemic test with repeated daily dosing for six
days showed that both metformin- and ME-treated groups had significantly reduced BGLs, as compared
to the control. The present study depicted that different doses of ME reduced BGLs in a dose-dependent
manner. Administration of different doses also showed that the minimum dose of ME that still possessed
antihyperglycemic activity was 250 mg/kg.
The present study further investigated two possible antidiabetic mechanisms of action of
S. polyanthum ME in vitro. The averted jejunal sac method of Wilson and Wiseman (1954), with
modifications, was used to investigate the effect of ME on glucose absorption in the intestine. Glucose
uptake by the muscles was examined using rat isolated abdominal muscles according to Gray and Flat
(1998) with some modifications [21].
Blood glucose levels are maintained within a narrow range by homeostatic mechanisms [5]. Dietary
complex carbohydrates are broken down to simple sugars in the gastrointestinal tract by the action of
glucosidases [6]. Only monosaccharides, such as glucose and fructose, can be transported out of the
intestinal lumen and into the bloodstream. Complex starches, oligosacharides, and disaccharides must
be broken down into their individual monosaccharides before being absorbed in the duodenum and
the upper jejunum. This digestion is facilitated by enteric enzymes, including pancreatic α-amylase
and α-glucosidase, that are attached to the brush border of the intestinal cells [18]. In diabetes
mellitus, control of postprandial plasma glucose levels is critical early in treatment. Inhibition of the
enzymes involved in the metabolism of carbohydrates is one of the therapeutic approaches for delaying
postprandial hyperglycemia. Acarbose is an antidiabetic drug that acts by delaying the digestion of
carbohydrates [22]. It is a competitive inhibitor of the intestinal α-glucosidase enzyme [18]. The averted
sac method used in this present study showed that ME managed to inhibit glucose absorption from the
intestine, yielding a similar effect to that of acarbose. This property may have partly contributed to the
antihyperglycemic activity of S. polyanthum leaf extract.
ME effect on muscle glucose uptake was also assessed in the current study with/without insulin and
with the use of metformin as a positive control. The major effect of insulin on the muscles is to stimulate
the translocation of the insulin-responsive glucose transporter, glucose transporter-4 (GLUT4), from the
intracellular vesicles to the cell surface; hence, it promotes amino acid uptake, stimulates the ribosomal
protein synthesis machinery, and increases the rate of glycogen synthase activity and subsequent
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glycogen storage, while decreasing the rate of glycogen breakdown [23–25]. Metformin, a biguanide,
is an insulin-sensitizing agent with potent antihyperglycemic properties [26]. Due to its actions via
insulin receptors and glucose transporters [27], it reduces glucose absorption in the small intestines;
increases glucose uptake into the cells and its use by target tissues; decreases plasma free fatty acid
concentrations; and inhibits the process of gluconeogenesis, thereby decreasing insulin resistance. The
activation of AMP-dependent protein kinase (AMPPK) plays an important role in these processes [25].
Since insulin resistance contributes greatly to the metabolic syndrome and is the major cause of type 2
diabetes mellitus, treatment with insulin sensitizers may ameliorate the pathophysiological abnormalities
of the metabolic syndrome [26]. Biguanides activate AMPPK to block the breakdown of fatty acids, and
to inhibit hepatic gluconeogenesis and glycogenolysis [24,28]. The effect of metformin on the peripheral
insulin-sensitive tissues requires the presence of insulin for a full action [26]. In the absence of added
insulin, there would only be minor effects [29]. Nevertheless, the direct effect of the drug on the glucose
transport system has been proven as it enhanced glucose analogue transport in a fashion independent
of insulin [21,30]. In the isolated abdominal muscle model of the present study, S. polyanthum leaf ME
enhanced glucose uptake by the muscles both with and without the presence of insulin, which was similar
to the behavior of metformin. In the presence of insulin, the extract enhanced the sensitivity of insulin to
increase the uptake of glucose, whereas in the absence ofinsulin, the action was probably due to an effect
on the glucose transporters that directly contributed to the uptake of glucose. This finding supported the
previous in vivo studyin the streptozotocin-induced diabetic rat model, and this mechanism contributed
to the antihyperglycemic action of S. polyanthum leaves.
Investigation of the phytochemical compounds present in the methanolic extract of S. polyanthum
leaves showed it to contain tannins, flavonoids, glycosides and alkaloids. Previously, it has been shown
that the administration of tannin fractions from Ficus racemosa for 30 days significantly reversed the
increase of the blood glucose levels of an STZ-induced hypercholesterolemia-associated diabetic rat
model [31]. Furthermore, some flavonoids have been reported to have antihyperglycemic activity
through various mechanisms of action, such as the inhibition of α-glucosidase and the increment of
blood insulin levels [32,33]. Moreover, certain flavonoids, e.g., quercetin, glycoside [34] and phytol
have been known to be able to regenerate pancreatic β-cells [35]. On the other hand, alkaloid-rich
fractions of Capparis decidua showed antidiabetic potential in mice [36]. Other studies reported that
alkaloids (vindoline, vindolidine, vindolicine and vindolinine) induced relatively high glucose uptake
in amouse β-TC6 pancreatic cell line and mouse myoblast (skeletal muscle) C2C12 cells. Improving
glucose uptake by pancreatic or muscle cells could reduce hyperglycemia in type 2 diabetes [37].
The GC-MS analysis of ME showed the presence of squalene, a triterpene that is an isoprenoid
compound [38]. It belongs to the terpenoid family and has a similar structure to β-carotene [39].
It contains six isoprene units andhas been known to possess several beneficial properties [38], including
an antioxidant activity [40]. Squalene has been presented in several studies as a compound that
contributes to the antihyperglycemic activity of plants. n-Hexadecanoic acid, octadecanoic acid and
squalene were present among the phytochemicals in Mucuna pruriens and Cynodondactylon and showed
an antihyperglycemic activity on STZ-induced diabetic rats [37,41]. The hypoglycemic action of
the fruit seed extract of Syzygium cumini, which contains triterpenes, has also been experimentally
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verified [16]. Squalene obtained from plants [42,43] acts as an α-glucosidase inhibitor [44] and may
increase insulin secretion [45].
5. Conclusions
In conclusion, the antihyperglycemic effect of the methanolic extract of S. polyanthum leaf may be
attributed to the presence of flavonoids, glycosides and squalene. The effect is probably exerted by
the extra-pancreatic pathway via inhibition of intestinal glucose absorption and enhancement of glucose
uptake by the muscles.
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